Skip to main content
. 2022 Oct 12;12(20):3567. doi: 10.3390/nano12203567

Table 6.

The pre-clinical studies of Thermo-sensitive MNPs in MHT therapy for theranostic purposes.

Formula Shell Application Status Procedure Results Ref
Zn0.1Fe0.9Fe2O4-Ge-Ag Ge/Ag -Contrast agent in MM-USI
-Heat mediator in MHT
Pre-clinical MHT
in phantom
-Synthesizing Zn-doped MNPs by co-precipitation (Zn0.1Fe0.9Fe2O4)
-Manufacturing Ge/Ag phantom
-Coating MNPs by Ge/Ag
-Tissue mimicking (elasticity and acoustic) generating phantom
-Applying PCC to produce powerful MF
-Cheap, non-invasive, and no ionizing effect
-MM-USI provided real-time mapping of MNPs distribution,
-MM-USI demonstrated successful 2D Temp monitoring prior and during MHT (for any depth within US limitation)
[233]
Fe3O4 No surfactant/capping materials -Heat mediator in MHT
-Sonosensitizer in US
In vitro
In vivo
-Preparing Fe3O4 MNPs by co-precipitation
-Dispersing into saline to produce MNFs
-The MNFs and US-TS produced a major rise in the cytotoxicity response of EACCs in rats
-Ineffective for deep-seated tumors
[234]
ZnMn-IONCs–PEG-PCL-SiNc PEG-PCL -heat mediator in MHT by AMF In vitro
In vivo
-Fabricating Zn-Mn-substituted IONPS via thermal decomposition.
-Synthesizing IONCs by adding Zn-Mn-dopped IONPs and PEG-PCL in THF (Zn-MN-IONCs-PEG-PCL).
-Loading SiNc onto IONCs
-Doping of Zn-Mn/Fe increased adsorption rate of IONPs and improved heat efficiency.
-Encapsulation by PEG-PCL caused the MNPs to cluster inside the shell and have a higher heat-efficiency.
-Over 90% apoptosis of DU145 cells by MHT.
-The shrinkage and inhibition of prostate tumor following four cycles of MH treatment.
-No toxicity to healthy cells.
-No weight loss in DU145-bearing mice.
[236]

Gelatin (Ge), Agar (Ag), Magnetomotive-ultrasound imaging (MM-USI), ultrasound (US), Ultrasound thermometry (UST), temperature (Temp), magnetic hyperthermia (MHT), Pancake coil (PCC), Ehrlich ascites carcinoma cells (EACCs), Magnetic nanofluids (MNFs), Ultrasound thermometry strain imaging (US-TS), Methoxy poly(ethylene glycol)-b-poly(ε-caprolactone) (PEG-PCL), Tetrahydrofuran (THF), Silicon naphthalocyanine (SiNc).